Sexually transmitted co-infections increase HIV risk: study

by Chantall Van Raay

(Medical Xpress) -- Bacterial and viral sexually transmitted infections can exacerbate HIV replication in co- infected individuals, a team of Canadian researchers led by Charu Kaushic, associate professor of pathology and molecular medicine, has found.

"While sexually transmitted infections are associated with increased HIV-1 susceptibility and viral shedding in the genital tract, the mechanisms underlying this association are poorly understood," said Kaushic about the study that appears online this month in the . "Our research has found that normal response to these infections by the epithelial cells (the cells that line the genital tract) can lead to increased in the ."

Through this study, Victor Ferreira, a graduate student in Kaushic's lab revealed how bacterial (gonorrhoea) and viral () sexually transmitted infections can increase HIV replication in co-infected individuals, opening new doors of understanding.

"Clinical studies have clearly shown that co-infection with herpes and gonorrhoea makes HIV infection worse and large trials have been conducted to study if controlling these infections can make less invasive and less transmissible," says Kaushic, a member of McMaster's Institute for Infectious Disease Research.

"The benefit of treating co-infections has not been as impressive as was expected, and this study increases our understanding of why that might be. We discovered that inflammation plays a key role in HIV replication. It's not necessary that if you control those infections, the inflammation is gone. So it might be useful, that in addition to treating these co- infections with antibiotics or antivirals, to control the inflammation and this might be more effective in stopping HIV replication rather than controlling just the infection."

Related Stories

Herpes drug inhibits HIV replication, but with a price

Nov 06, 2008

The anti-herpes drug acyclovir can also directly slow down HIV infection by targeting the reverse transcriptase (RT) enzyme, researchers report in this week's JBC. This beneficial effect does pose a risk though, as HIV-in ...

Recommended for you

Model explains why HIV prevention dosing differs by sex

19 hours ago

A mathematical model developed by NIH grantees predicts that women must take the antiretroviral medication Truvada daily to prevent HIV infection via vaginal sex, whereas just two doses per week can protect men from HIV infection ...

Tourism as a driver of illicit drug use, HIV risk in the DR

Oct 29, 2014

The Caribbean has the second highest global human immunodeficiency virus (HIV) prevalence in the world outside of Sub-Saharan Africa, with HIV/AIDS as leading cause of death among people aged 20–59 years within the region. ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.